HB 308 would require certain people convicted of sex crimes involving victims under age 12 to undergo medroxyprogesterone acetate treatment, or a chemical equivalent, as an additional penalty. The bill directs the court to identify in the judgment whether the victim was under 12, and requires treatment to begin no later than one month before release from custody and continue through probation, parole, or postincarceration supervision.
The bill also sets out procedures for medical evaluation, informed consent disclosures, and release of medical records before and during treatment. It assigns the Department of Corrections, or its contractors, responsibility for administering the treatment and requires the department to adopt regulations to implement the law. The bill further provides that the offender generally pays the costs, but the Commonwealth pays if the person is found indigent, and it authorizes reincarceration for intentional violations of the treatment requirement.
Impact
HB 308 would create a new section in KRS Chapter 532 and add a mandatory post-conviction treatment requirement for a narrow category of sex offenders. It would affect sentencing and supervision practices for offenders convicted of sex crimes against children under 12, expand the Department of Corrections’ duties, and require coordination with courts, medical providers, and probation/parole supervision. It also establishes cost-allocation rules and record-release requirements that would affect both offenders and the state when indigency is found.
Sentiment
No committee transcript or recorded vote information is available, so the bill’s sentiment can only be inferred from its text and status. The measure appears to be framed as a public-safety and child-protection bill, suggesting likely support from proponents of tougher sex-offender controls. At the same time, the mandatory medical treatment, compelled record disclosure, and reincarceration provisions suggest the bill could draw concern from civil liberties, medical ethics, and due process perspectives.
Contention
The main points of contention are likely to be the mandatory nature of medroxyprogesterone acetate treatment, sometimes described as chemical castration, and whether requiring it as an additional penalty is constitutional, medically appropriate, or ethically permissible. Another likely issue is the bill’s requirement that offenders authorize release of medical records and the possibility of reincarceration for noncompliance. Cost responsibility may also be disputed, especially the provision shifting expenses to the Commonwealth for indigent persons and allowing periodic review of indigency status.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)